Proteomic and microRNA data clarifying the effects of telomere shortening on cancer cells

by Orit Uziel, Meir Lahav
Published 2015-03-01

The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma

by Orit Uziel, Olga Cohen, Einat Beery, Jardena Nordenberg, Meir Lahav
Published 2014-12-01

Telomere Length Changes during Critical Illness: A Prospective, Observational Study

by Benjamin Zribi, Orit Uziel, Meir Lahav, Ronit Mesilati Stahy, Pierre Singer
Published 2019-09-01

The Effect of Ethanol on Telomere Dynamics and Regulation in Human Cells

by Tomer Harpaz, Heba Abumock, Einat Beery, Yonatan Edel, Meir Lahav, Uri Rozovski, Orit Uziel
Published 2018-10-01

The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells

by Naama Shalem-Cohavi, Einat Beery, Jardena Nordenberg, Uri Rozovski, Pia Raanani, Meir Lahav, Orit Uziel
Published 2019-05-01

Peripheral blood telomere alterations in ground glass opacity (GGO) lesions may suggest malignancy

by Matthew Koslow, David Shitrit, Lilach Israeli‐Shani, Orit Uziel, Einat Beery, Alexandra Osadchy, Yael Refaely, Gali Epstein Shochet, Aliza Amiel
Published 2019-04-01

Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms.

by Orit Uziel, Einat Beery, Vladimir Dronichev, Katty Samocha, Sergei Gryaznov, Lola Weiss, Shimon Slavin, Michal Kushnir, Yardena Nordenberg, Claudette Rabinowitz, Baruch Rinkevich, Tania Zehavi, Meir Lahav
Published 2010-01-01